Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marina A. Lyadova"'
Autor:
Marina A. Lyadova, Denis S. Fedorinov, Julia S. Mansurova, Evgeniya S. Kuzmina, Yury S. Esakov, Konstantin V. Lyadov, Vsevolod N. Galkin, Irina V. Poddubnaya
Publikováno v:
Consilium Medicum, Vol 26, Iss 6, Pp 362-367 (2024)
Background. Small cell lung cancer (SCLC), predominantly due to smoking, is a highly differentiated, rapidly growing epithelial cell carcinoma of high malignancy originating from bronchial neuroendocrine cells. Almost 70% of SCLC patients have metast
Externí odkaz:
https://doaj.org/article/adc860db45b147ad9c70a80293786c03
Autor:
Marina A. Lyadova, Tatiana A. Nersesova, Anastasia A. Zhuravleva, Denis S. Fedorinov, Anna A. Dudnik, Elena A. Denisova, Margarita V. Nosova, Olesya A. Pardabekova, Kristina N. Lisitsyna, Veronika M. Tuleiko, Olesya A. Bikmurzina
Publikováno v:
Современная онкология, Vol 25, Iss 4, Pp 498-503 (2023)
Background. Alopecia is one of the main side effects of anticancer chemotherapy and has a significant impact on patients’ appearance, quality of life, social adaptation and mental health of cancer patients. Estimated number of new cancer diagnosis
Externí odkaz:
https://doaj.org/article/708f34b0bc344f41ab5d9ad2e63870c6
Autor:
Vladimir K. Lyadov, Denis S. Fedorinov, Marina A. Lyadova, Ekaterina A. Khristenko, Tatyana S. Boldyreva, Vsevolod N. Galkin
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 278-282 (2023)
Background. The course of colon cancer (CC) is burdened in many patients with elderly and senile age, the presence of severe comorbidities, and complications of the malignancy. The complex treatment for advanced colon tumors also requires the search
Externí odkaz:
https://doaj.org/article/1342b6a8b58e4676bfeab5d7247b27e7
Autor:
Marina A. Lyadova, Denis S. Fedorinov, Evgeniya S. Kuzmina, Tatiana G. Antonova, Valentina K. Sokolskaya
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 392-396 (2023)
Background. COVID-19 (COrona VIrus Disease 2019) is a serious threat to cancer patients, who are at an increased risk of severe infection complications. Pre-exposure prophylaxis with a combination of monoclonal antibodies, tixagevimab-cilgavimab (Evu
Externí odkaz:
https://doaj.org/article/b3cc7fa8dbb2432281fc508ed65d0c07
Publikováno v:
Современная онкология, Vol 25, Iss 1, Pp 140-144 (2023)
Nowadays, checkpoint inhibitors are widely used in the treatment of various types of cancer. However, its use is often accompanied by the development of immune-mediated adverse events (IAEs) of various systems and organs. Aim description of the featu
Externí odkaz:
https://doaj.org/article/af0a959144bd413f84539f1a1b65aa79
Autor:
Marina A. Lyadova, Vladimir K. Lyadov
Publikováno v:
Современная онкология, Vol 23, Iss 2, Pp 319-326 (2021)
Immune-mediated adverse events (imAEs) are complications of therapy with immune checkpoint inhibitors, which arise as a result of autoimmune inflammation. The article summarizes systemic (fatigue, fever), cutaneous (rash, itching), gastrointestinal (
Externí odkaz:
https://doaj.org/article/3a154e511d494ed0b9aa3f44adddd121
Autor:
Denis S. Fedorinov, Rustam N. Geidarov, Igor A. Shashkov, Vladimir M. Mikhailovich, Marina A. Lyadova, Ilya A. Pokataev, Vladimir K. Lyadov
Publikováno v:
Современная онкология, Vol 23, Iss 2, Pp 314-318 (2021)
Aim. To assess the association between the carriage of minor allelic variants of 8 genes that encode key enzymes involved in the metabolism of anticancer drugs (DPYD, GSTP1, MTHFR, UGT1A1) and cell repair (XPC, ERCC1, TYMP, NQO1) and the severity of
Externí odkaz:
https://doaj.org/article/967f135a4f9d43188148f60682a5b165
Autor:
Vladimir K. Lyadov, Rustam N. Geidarov, Marina A. Lyadova, Igor A. Shashkov, Denis S. Fedorinov, Ilya Pokataev, V. M. Mikhailovich
Publikováno v:
Современная онкология, Vol 23, Iss 2, Pp 314-318 (2021)
Aim. To assess the association between the carriage of minor allelic variants of 8 genes that encode key enzymes involved in the metabolism of anticancer drugs (DPYD, GSTP1, MTHFR, UGT1A1) and cell repair (XPC, ERCC1, TYMP, NQO1) and the severity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ff0fa3abf981026ce9d79f55210ff2
https://modernonco.orscience.ru/1815-1434/article/viewFile/75937/pdf
https://modernonco.orscience.ru/1815-1434/article/viewFile/75937/pdf
Publikováno v:
Современная онкология, Vol 20, Iss 2, Pp 56-60 (2018)
Gastric cancer has one of the leading positions in the world in the prevalence and mortality among malignant tumors. The results of surgical treatment of locally advanced gastric cancer remain generally poor due to the high rate of relapse after surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7273266062129e9e788c86dc3b010f10
https://modernonco.orscience.ru/1815-1434/article/viewFile/29552/pdf
https://modernonco.orscience.ru/1815-1434/article/viewFile/29552/pdf